The price of more than 20 kinds of Chinese patent medicines under Jiuzhitang increased
Cailian news agency, Jan. 4, learned from Jiuzhitang that the company has officially issued a price adjustment notice to customers on January 1. Considering the impact of the price increase of raw materials, it has raised the supply price or recommended retail price of 21 Chinese patent medicines, including Angong Niuhuang Pill, Liuwei Dihuang pill and Xiaoyao Pill, with a price adjustment range of 6% - 30%, Among them, the price of Angong Niuhuang Pill increased by 12% - 25%, and Liuwei Dihuang pill, which accounts for the largest proportion of OTC product revenue, increased by 10%. It is understood that these 21 drugs account for about 30% of the company's OTC drug business revenue by 2020.
This text is a result of machine translation.
Related companies：
Briefing Jun 28, 2022 12:29 PM
· Financials
Many banks have issued documents to stop the intelligent investment advisory business. Insiders: it may be restarted after the regulatory rules are released
In-depth
Briefing Jun 27, 2022 03:19 PM
· Financials
Mihayou v. Minmetals trust case will hold a court session, and it is difficult to recover the funds involved in the thunderstorm products
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Jun 29, 2021 11:48 PM
Oct 27, 2020 01:11 PM
Briefing Jun 17, 2022 10:05 PM
· Financials
Source: at present, the central bank has not accepted the application of ant group to establish a financial holding company
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Apr 23, 2024 02:21 PM